Inactivating Icmt ameliorates K-RAS-induced myeloproliferative diseaseWAHLSTROM, Annika M; CUTTS, Briony A; MENG LIU et al.Blood. 2008, Vol 112, Num 4, pp 1357-1365, issn 0006-4971, 9 p.Article

STAT3 Plays a Critical Role in KRAS-Induced Pancreatic TumorigenesisCORCORAN, Ryan B; CONTINO, Gianmarco; DESHPANDE, Vikram et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 14, pp 5020-5029, issn 0008-5472, 10 p.Article

Neoplastic transformation of endocervicosis into an extraovarian mucinous cystadenocarcinomaKRUSE, Arnold-Jan; SLANGEN, Brigitte; DUNSELMAN, Gerard A et al.Human pathology. 2011, Vol 42, Num 5, pp 743-748, issn 0046-8177, 6 p.Article

Clinical Relevance of KRAS in Human CancersJANCIK, Sylwia; DRABEK, Jiří; RADZIOCH, Danuta et al.Journal of Biomedicine and Biotechnology (Print). 2010, Vol 2010, issn 1110-7243, 150960.1-150960.13, 2Article

K-ras codon-specific mutations produce distinctive metabolic phenotypes in human fibroblastsVIZAN, Pedro; BOROS, Laszlo G; FIGUERAS, Agnes et al.Cancer research (Baltimore). 2005, Vol 65, Num 13, pp 5512-5515, issn 0008-5472, 4 p.Article

Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesisVITALE-CROSS, Lynn; AMORNPHIMOLTHAM, Panomwat; FISHER, Galen et al.Cancer research (Baltimore). 2004, Vol 64, Num 24, pp 8804-8807, issn 0008-5472, 4 p.Article

Inducible activation of oncogenic K-ras results in tumor formation in the oral cavityCAULIN, Carlos; NGUYEN, Thao; LONGLEY, Mary A et al.Cancer research (Baltimore). 2004, Vol 64, Num 15, pp 5054-5058, issn 0008-5472, 5 p.Article

KRAS Mutation: Should We Test for It, and Does It Matter?ROBERTS, Patrick J; STINCHCOMBE, Thomas E.Journal of clinical oncology. 2013, Vol 31, Num 8, pp 1112-1120, issn 0732-183X, 9 p.Article

Oncogenic Kras Promotes Chemotherapy-Induced Growth Factor Shedding via ADAM17VAN SCHAEYBROECK, Sandra; KYULA, Joan N; FENTON, Audrey et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 3, pp 1071-1080, issn 0008-5472, 10 p.Article

Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutationsZENKER, Martin; LEHMANN, Katarina; MUNDLOS, Stefan et al.Journal of medical genetics. 2007, Vol 44, Num 2, pp 131-135, issn 0022-2593, 5 p.Article

4-Hydroxytamoxifen Induces Autophagic Death through K-Ras DegradationKOHLI, Latika; KAZA, Niroop; CORIC, Tatjana et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 14, pp 4395-4405, issn 0008-5472, 11 p.Article

KRAS mutations in historical tumour specimens of the Viennese Museum of pathological anatomySEDIVY, Roland; KALIPCIYAN, Maria; PATZAK, Beatrix et al.Histopathology. 2011, Vol 58, Num 5, pp 792-796, issn 0309-0167, 5 p.Article

Single Copies of Mutant KRAS and Mutant PIK3CA Cooperate in Immortalized Human Epithelial Cells to Induce Tumor FormationWANG, Grace M; YUEN WONG, Hong; GARAY, Joseph P et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 11, pp 3248-3261, issn 0008-5472, 14 p.Article

Sanger sequencing in routine KRAS testing: a review of 1720 cases from a pathologist's perspectiveMALAPELLE, Umberto; BELLEVICINE, Claudio; VITA, Giulia et al.Journal of clinical pathology. 2012, Vol 65, Num 10, pp 940-944, issn 0021-9746, 5 p.Article

The Detection of Double Mutations in KRAS Depends on the Mutation-Detection Assay UsedHOSTEIN, Isabelle; LAMY, Aude; FAUR, Nicolas et al.Clinical chemistry (Baltimore, Md.). 2011, Vol 57, Num 7, pp 1077-1079, issn 0009-9147, 3 p.Article

Differential antiproliferation effect of 2'-benzoyloxycinnamaldehyde in K-ras-transformed cells via downregulation of thiol antioxidantsOCK, Jiyeon; LEE, Hae-Ahm; ISMAIL AHMED ISMAIL et al.Cancer science. 2011, Vol 102, Num 1, pp 212-218, issn 1347-9032, 7 p.Article

Fc-engineered EGF-R antibodies mediate improved antibody-dependent cellular cytotoxicity (ADCC) against KRAS-mutated tumor cellsSCHLAETH, Martin; BERGER, Sven; DERER, Stefanie et al.Cancer science. 2010, Vol 101, Num 5, pp 1080-1088, issn 1347-9032, 9 p.Article

Genomic and Biological Characterization of Exon 4 KRAS Mutations in Human CancerJANAKIRAMAN, Manickam; VAKIANI, Efsevia; PERSAUD, Yogindra et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 14, pp 5901-5911, issn 0008-5472, 11 p.Article

Oncogenic Kras-induced leukemogeneis : hematopoietic stem cells as the initial target and lineage-specific progenitors as the potential targets for final leukemic transformationJING ZHANG; JING WANG; YANGANG LIU et al.Blood. 2009, Vol 113, Num 6, pp 1304-1314, issn 0006-4971, 11 p.Article

Oncogenic K-RAS subverts the antiapoptotic role of N-RAS and alters modulation of the N-RAS : gelsolin complexKELLER, J. W; HAIGIS, K. M; FRANKLIN, J. L et al.Oncogene (Basingstoke). 2007, Vol 26, Num 21, pp 3051-3059, issn 0950-9232, 9 p.Article

Rce1 deficiency accelerates the development of K-RAS-induced myeloproliferative diseaseWAHLSTROM, Annika M; CUTTS, Briony A; KARLSSON, Christin et al.Blood. 2007, Vol 109, Num 2, pp 763-768, issn 0006-4971, 6 p.Article

Genotype-specific signal generation based on digestion of 3-way DNA junctions : Application to KRAS variation detectionAMICARELLI, Giulia; ADLERSTEIN, Daniel; SHEHI, Erlet et al.Clinical chemistry (Baltimore, Md.). 2006, Vol 52, Num 10, pp 1855-1863, issn 0009-9147, 9 p.Article

BRAF gene mutations are rare events in gastroenteropancreatic neuroendocrine tumorsTANNAPFEL, Andrea; VOMSCHLOSS, Susanne; KARHOFF, Dorothee et al.American journal of clinical pathology. 2005, Vol 123, Num 2, pp 256-260, issn 0002-9173, 5 p.Article

Immunization with mutant p53- and K-ras-derived peptides in cancer patients : Immune response and clinical outcomeCARBONE, David P; CIERNIK, I. Frank; PENDLETON, C. David et al.Journal of clinical oncology. 2005, Vol 23, Num 22, pp 5099-5107, issn 0732-183X, 9 p.Article

K-ras mutation influences macroscopic features of gastric carcinomaYASHIRO, Masakazu; NISHIOKA, Nobuaki; HIRAKAWA, Kosei et al.The Journal of surgical research. 2005, Vol 124, Num 1, pp 74-78, issn 0022-4804, 5 p.Article